Search
Font size
click to adjust
Page tools
- Add to info basket
- Black-and-white version

- Text version
- Printer friendly version
- Bookmark this page
Financial Report
Individual solutions for individual needs
The future of medicine lies in individual approaches and in building bridges between prevention, diagnosis and therapy.
Bayer Schering Pharma meets this challenge with proven, successful products based on many decades of knowledge and experience. more
Bayer Schering Pharma meets this challenge with proven, successful products based on many decades of knowledge and experience. more
BENEFIT Follow-Up Study
Early Treatment of MS Can Delay Permanent Disabilities.
Treating patients who are showing the first signs of multiple sclerosis with beta interferon significantly delays the onset of clinically estab-lished MS and the occurrence of permanent disabilities. These are the results of a follow-up to the BENEFIT study recently published in the prestigious journal The Lancet. more
Treating patients who are showing the first signs of multiple sclerosis with beta interferon significantly delays the onset of clinically estab-lished MS and the occurrence of permanent disabilities. These are the results of a follow-up to the BENEFIT study recently published in the prestigious journal The Lancet. more
Improving Women's Healthcare - Empowering Women
Learn more about the health topic Women's Healthcare and the activities of Bayer Schering Pharma
Therapeutic Areas A-Z
Here you get an overview of our therapeutic areas more
Diagnostic Imaging:
X-ray contrast media, Contrast agents for magnetic resonance imaging.
General Medicine:
Anti-infectives, Men’s Healthcare, Cardiovascular and metabolic diseases, Thromboembolic diseases.
Specialty Medicine:
Hemophilia, Products for treating leukemias and lymphomas, Drugs for solid-tumor therapy and for treating diseases of the central nervous system, age-related eye diseases.
Women´s Healthcare:
Contraception, Menopausal Complaints, Gynecological therapies.
Diagnostic Imaging:
X-ray contrast media, Contrast agents for magnetic resonance imaging.
General Medicine:
Anti-infectives, Men’s Healthcare, Cardiovascular and metabolic diseases, Thromboembolic diseases.
Specialty Medicine:
Hemophilia, Products for treating leukemias and lymphomas, Drugs for solid-tumor therapy and for treating diseases of the central nervous system, age-related eye diseases.
Women´s Healthcare:
Contraception, Menopausal Complaints, Gynecological therapies.


